First Trust Advisors LP increased its stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 6.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,856 shares of the company’s stock after acquiring an additional 393 shares during the quarter. First Trust Advisors LP’s holdings in BlackRock Health Sciences Trust were worth $260,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of BME. Raymond James Financial Inc. purchased a new position in shares of BlackRock Health Sciences Trust in the 4th quarter valued at $3,250,000. Janney Montgomery Scott LLC lifted its stake in BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after acquiring an additional 9,455 shares during the period. Hara Capital LLC acquired a new position in shares of BlackRock Health Sciences Trust in the 4th quarter valued at about $832,000. Yakira Capital Management Inc. acquired a new stake in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $322,000. Finally, Invesco Ltd. boosted its stake in shares of BlackRock Health Sciences Trust by 8.9% during the 4th quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock worth $8,470,000 after acquiring an additional 18,213 shares in the last quarter.
BlackRock Health Sciences Trust Stock Down 0.7 %
Shares of BME stock opened at $36.12 on Friday. BlackRock Health Sciences Trust has a 1-year low of $34.18 and a 1-year high of $42.64. The stock has a 50 day simple moving average of $37.41 and a 200-day simple moving average of $38.85.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- Why Are Stock Sectors Important to Successful Investing?
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
- Insider Trading – What You Need to Know
- Here’s The Reason Goldman Sachs Is Bullish On MercadoLibre Stock
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Analyst-Favorite Bitcoin Miner CleanSpark: Worth the Hype?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.